Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians

Fecha de publicación

2023-05-29T10:29:31Z

2023-05-29T10:29:31Z

2022-07-29

2023-05-02T07:57:26Z

Resumen

Chronic obstructive pulmonary disease (COPD) and lung cancer (LC) are common global causes of morbidity and mortality. Because both diseases share several predisposing risks, the two diseases may occur concurrently in susceptible individuals. The diagnosis of COPD has important implications for the diagnostic approach and treatment options if lesions concerning for LC are identified during screening. Importantly, the presence of COPD has significant implications on prognosis and management of patients with LC. In this monograph, we review the mechanistic linkage between LC and COPD, the impact of LC screening in patients at risk, and the implications of the presence of COPD on the approach to the diagnosis and treatment of LC. This manuscript succinctly reviews the epidemiology and common pathogenetic factors for the concurrence of COPD and LC. Importantly for the clinician, it summarizes the indications, benefits, and complications of LC screening in patients with COPD, and the assessment of risk factors for patients with COPD undergoing consideration of various treatment options for LC.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Documentos relacionados

Reproducció del document publicat a: https://doi.org/10.15326/jcopdf.2022.0296

Chronic Obstructive Pulmonary Diseases, 2022, vol.9, núm. 3, p. 454-476

https://doi.org/10.15326/jcopdf.2022.0296

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

(c) COPD Foundation, 2022

Este ítem aparece en la(s) siguiente(s) colección(ones)